Zdrowie i gospodarka · 23/03/2022

FDA Releases Final Guidance on Compliance with 21 CFR Part 4 for Ophthalmic Products

The Food and Drug Administration (FDA) has made available a final guidance document outlining its policy on compliance with FDA regulations for ophthalmic drugs packaged with eye cups, droppers, and other dispensers, as required by 21 CFR part 4.